2 European Projects Found
Searched on 125080 European Projects
FINISHED
Beta cell preservation via antigen-specific immunotherapy in Type 1 Diabetes: Enhanced Epidermal Antigen Delivery Systems (EE-ASI)
Start date: Sep 1, 2012, End date: May 31, 2017,
Current approaches to improving glycaemic control in type 1 diabetes are centered on increasingly complex insulin delivery systems. However, less than 30% of patients can achieve target levels of glucose control with this approach even in a clinical trial setting and many patients are either unable or unwilling to make the personal commitment required. By contrast, preservation of even sma ...
Read Project
8
Partners Participants
FINISHED
Beta Cell Therapy in Diabetes (BETACELLTHERAPY)
Start date: Jan 1, 2010, End date: Jun 30, 2015,
Type 1 diabetes is a serious chronic disease with major health risks and heavy burden on patients and society. It is caused by massive immune-mediated loss of insulin-producing beta cells in the pancreas that can so far not be locally corrected. A cellular allotransplant in the liver can install a new beta cell mass but the size is insufficient and the procedure faces limitations of donor shortage ...
Read Project
